ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2534

Increased Risk of Allergic Conditions in Children Born to Women with SLE

Julie Couture1, Moshe Ben-Shoshan1, Christian A. Pineau2, Susan Scott3, Ann E. Clarke4, Sasha Bernatsky2 and Evelyne Vinet2, 1McGill University Health Centre, Montreal, QC, Canada, 2Divisions of Rheumatology and Clinical Epidemiology, McGill University Health Centre, Montreal, QC, Canada, 3Clinical Epidemiology, Research Institute of the McGill University Health Centre, Montreal, QC, Canada, 4Division of Rheumatology, University of Calgary, Calgary, AB, Canada

Meeting: 2015 ACR/ARHP Annual Meeting

Date of first publication: September 29, 2015

Keywords: SLE and pregnancy

  • Tweet
  • Email
  • Print
Session Information

Date: Tuesday, November 10, 2015

Title: Reproductive Issues in Rheumatic Disorders: Basic and Clinical Aspects Poster Session

Session Type: ACR Poster Session C

Session Time: 9:00AM-11:00AM

Background/Purpose: Allergic conditions seem to be more prevalent in patients with SLE than in the general population. To date, a handful of small observational studies have evaluated the risk of allergic conditions in offspring born to women with SLE, showing a potentially increased likelihood. In a large population-based study, we aimed to determine if children born to SLE mothers have an increased risk of allergic conditions compared to children born to mothers without SLE. 

Methods: The “Offspring of SLE mothers Registry (OSLER)” includes all women who had ≥1 hospitalization for delivery after SLE diagnosis, identified through Quebec’s universal healthcare databases (1989-2009). OSLER also includes a randomly selected control group of women, matched at least 4: 1 for age and year of delivery, who did not have a diagnosis of SLE prior to or at the time of delivery. We identified children born live to SLE mothers and their matched controls, and ascertained allergic conditions (including asthma, allergic rhinitis, eczema, cutaneous allergy, urticaria, angioedema, and anaphylaxis) based on ≥1 hospitalization or ≥2 physician visit with a relevant diagnostic code. We performed multivariate analyses to adjust for maternal age, education, ethnicity, and obstetrical complications (i.e. preterm birth, small for gestational age), as well as calendar year of birth and sex of the child. Moreover, in a subsample analysis of children with maternal public drug coverage throughout pregnancy, we further adjusted for relevant maternal medications (i.e. antimalarials, corticosteroids, and immunosuppressive drugs). 

Results: 509 women with SLE had 719 children, while 5824 matched controls had 8493 children. Mean follow-up was 9.1 (SD 5.8) years. As opposed to controls, children born to mothers with SLE experienced more allergic conditions [66.1% (95% CI 62.5, 69.5) versus 59.3% (95% CI 58.3, 60.4)]. In SLE offspring, the most frequently observed allergic conditions were eczema (43.8%) and asthma (28.5%), while anaphylaxis was the least frequent (0.8%). In control children, eczema (38.9%) and asthma (25.4%) were also the most frequent, while anaphylaxis was the least frequent (0.3%). In multivariate analysis (n=9212), children born to SLE mothers had an increased risk of allergic conditions versus control children (OR 1.36, 95% CI 1.14,1.61). In the subsample analysis further controlling for relevant maternal medications (n=1925), though a trend remained for increased risk of allergic conditions for offspring of SLE mothers versus controls, due to reduced sample size the 95% CI was wider and included the null value (OR 1.23; 95% CI 0.79, 1.91).

Conclusion: Compared to children from the general population, children born to women with SLE have an increased risk of allergic conditions. Genetic factors, shared environmental exposures, as well as in utero exposure to maternal autoantibodies and cytokines might be at play. Further research is warranted to investigate the relative importance of these potential predisposing factors.


Disclosure: J. Couture, None; M. Ben-Shoshan, None; C. A. Pineau, None; S. Scott, None; A. E. Clarke, None; S. Bernatsky, None; E. Vinet, None.

To cite this abstract in AMA style:

Couture J, Ben-Shoshan M, Pineau CA, Scott S, Clarke AE, Bernatsky S, Vinet E. Increased Risk of Allergic Conditions in Children Born to Women with SLE [abstract]. Arthritis Rheumatol. 2015; 67 (suppl 10). https://acrabstracts.org/abstract/increased-risk-of-allergic-conditions-in-children-born-to-women-with-sle/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2015 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/increased-risk-of-allergic-conditions-in-children-born-to-women-with-sle/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology